Zhitong Finance App News, Dizhe Pharmaceutical (688192.SH) announced that due to personal capital requirements, Ms. Wu Qingyi plans to reduce her holdings by no more than 302,100 shares (including capital) through centralized bidding, accounting for no more than 0.0657% of the company's total share capital, accounting for no more than 25% of the company's shares before the current holdings reduction; Dr. Zhang Shiying (CHANG SHIH-YING) plans to reduce her holdings by no more than 16,000 shares (including capital) through centralized bidding, accounting for no more than 0.0035% of the company's total share capital The number of company shares held is not more than 25%. The holdings reduction period is from June 24, 2025 to September 23, 2025. The holdings reduction price will be determined according to the market price during the implementation period of the holdings reduction.

Zhitongcaijing · 05/19 11:57
Zhitong Finance App News, Dizhe Pharmaceutical (688192.SH) announced that due to personal capital requirements, Ms. Wu Qingyi plans to reduce her holdings by no more than 302,100 shares (including capital) through centralized bidding, accounting for no more than 0.0657% of the company's total share capital, accounting for no more than 25% of the company's shares before the current holdings reduction; Dr. Zhang Shiying (CHANG SHIH-YING) plans to reduce her holdings by no more than 16,000 shares (including capital) through centralized bidding, accounting for no more than 0.0035% of the company's total share capital The number of company shares held is not more than 25%. The holdings reduction period is from June 24, 2025 to September 23, 2025. The holdings reduction price will be determined according to the market price during the implementation period of the holdings reduction.